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Mycobacterium abscessus (M.abs) is a rapidly growing mycobacterial species that infects macrophages,
and is an important pathogen in patients with cystic ﬁbrosis. We studied the early stages of M.abs in-
fection of macrophages, with emphasis on the role of heme-oxygenase-1 (HO-1) in this infection. THP-1
cells were activated using TPA into macrophage-like cells and infected with M.abs for different time
points. M.abs infection robustly induced HO-1 expression in the THP-1 cells. Production of HO-1 was p38
MAPK-dependent, as p38 inhibitors suppressed HO-1 induction. Pretreatment with HO-1 inhibitors tin-
protoporphyrin (SnPP) signiﬁcantly inhibited M.abs growth inside macrophages. Furthermore, inhibiting
HO-1 using HO-1 siRNA or the HO-1 upstream signaling molecule; Nrf2 using Nrf2 siRNA resulted in
similar inhibition of M.abs. In contrast, inducing HO-1 did not increase M.abs intracellular growth above
control. Products of HO-1 metabolism of heme are bilirubin, biliverdin, carbon monoxide (CO) and iron.
The addition of either bilirubin or biliverdin, but not CO, completely restored the SnPP inhibitory effect
and partially that with HO-1 siRNA. To understand the mechanisms, we used Syto-62 labeled M.abs to
infect macrophages. Interestingly, HO-1 inhibition promoted M.abs-containing phagosome fusion with
lysosomes, which should enhance M.abs killing. M.abs infection enhanced THP-1 ROS production as
demonstrated by increased DHE, DCF ﬂuorescence, and EPR signal. HO-1 inhibition further increased ROS
production in infected macrophages. Our results indicate that HO-1 induction is important for M.abs
growth during the early stages of infection, and that the HO-1 products bilirubin and biliverdin, perhaps
through modulation of intracellular ROS levels, may be involved.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Mycobacterium abscessus (M.abs) is a rapidly growing non-tu-
berculous mycobacterial (NTM) species that infects macrophages
of the lungs and skin and causes a variety of clinical syndromes in
humans [1,2]. It has recently emerged as an important pathogen in
patients with cystic ﬁbrosis (CF), causing severe lung disease [3]
and multiple complications that prevent lung transplantation [4].
Moreover, despite conventional cross-infection prevention proce-
dures, frequent transmission of multidrug resistant NTM between
patients with CF still exists [5].
Heme oxygenase-1 (HO-1) – also known as heat-shock protein
32 – is the rate-controlling enzyme of cellular heme catabolism.
This microsomal enzyme acts on heme moieties to produceB.V. This is an open access article u
crobiology, University of Ne-
ter, Omaha, NE 68198-5900,
bdalla).equimolar amounts of carbon monoxide, iron (Fe), and biliverdin
that is in turn converted to bilirubin by biliverdin reductase [6,7].
The Fe is then stored in ferritin, limiting its ability to participate as
a catalyst through Fenton chemistry for production of cytotoxic
free radicals [8]. Both biliverdin and bilirubin are thought to play
an antioxidant role [9]. It was shown that HO-1 is induced by a
variety of stimuli, such as ROS, viral infection and bacterial en-
dotoxins, and appears to be protective in a variety of inﬂammatory
disease states [10–12] due to its ability to inhibit inﬂammation and
oxidative stress [13]. Moreover, induction of HO-1 suppresses
apoptotic cell death through activation of MAPK and PI3K path-
ways with possible involvement of CO [14–17]. In THP-1 cells, HO-
1 induction counteracted the effect of TNF-induced cell death via
Nrf2 activation [18]. This is potentially of importance to myco-
bacterial infection as it appears that macrophage apoptosis con-
tributes to host defense [19]. The role of CO in mycobacterial in-
fection has been described previously. It was shown that Myco-
bacterium tuberculosis (M.tb) senses host-derived CO produced
by HO-1 induction during macrophages infection [20], and COnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339 329activates the expression of dormancy (Dos) regulon [21], and other
CO resistance genes such as cor, that protect bacteria from host-
derived CO [22], and thus enhances mycobacterial survival in vivo
[20–22]. We have also shown that acquiring Fe is critical to the
metabolism and growth of mycobacteria and that limiting Fe
availability could be a strategy for novel antimicrobial agents
[23,24].
Little research has been conducted on M.abs pathogenesis. Like
other pathogenic mycobacterial species, M.abs infects and multi-
plies within human macrophages, reﬂecting their ability to evade
macrophage antimicrobial systems. Therefore, understanding the
mechanism whereby M.abs successfully infect macrophages and
ﬁnding approaches to reduce macrophage susceptibility to infec-
tion could lead to the development of novel antimicrobial agents
to combat the growing clinical problem of multidrug resistant M.
abs. The goal of this study is to assess the link between HO-1 and
M.abs infection of human macrophages and understand the me-
chanisms by which HO-1 controls M.abs proliferation inside the
infected macrophages.Control 4 hrs 6 hrs 8 hrs 12 hrs 24 hrs
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Fig. 1. M.abs increased HO-1 expression. TPA-differentiated THP-1 cells were in-
fected with M.abs for 1 h, washed and incubated in media containing gentamicin
until harvested at different time points. M.abs cfu were determined and cells were
prepared for immunoblotting as described in Materials and methods. (A) M.abs
showed robust intracellular growth, as shown by the increase in CFU at days 0, and
1 post-infection. (B) Proteins were run and HO-1 visualized by immunoblotting.
Results showed induction of HO-1 after infection. (C) Densitometric analysis of HO-
1 bands in (B). M.abs infection resulted in a signiﬁcant increase in expression of
HO-1 (n¼4, *indicates po0.001).Materials and methods
Materials
The p38 inhibitors; SB202190 hydrochloride was obtained from
(Santa Cruz Biotechnology, Inc., Dallas, TX) and SB203580 from
Cell Signaling Technology, Danvers, MA. The carbon monoxide
(CO) releasing molecule (tricarbonylchloro(glycinato)ruthenium
(II)) was purchased from Sigma, St. Louis, MO. Heme oxygenase-1
siRNA (h), Nrf2 siRNA (h), control siRNA, tin protoporphyrin IX
dichloride, bilirubin, biliverdin hydrochloride, protoporphyrin IX
cobalt chloride were all obtained from Santa Cruz Biotechnology.
Cell culture
THP-1 cells, a human monocyte-derived cell line, were ob-
tained from the American Type Culture Collection (ATCC, Mana-
ssas, VA). The cells were grown in suspension in RPMI medium
supplemented with 10% fetal bovine serum (FBS) and 1% peni-
cillin/streptomycin (Thermo Scientiﬁc, Waltham, MA). The cells
were cultured in 24-well tissue culture ﬂask at a density of 106
cells/well in the presence of 15 ng/ml of 12-O-tetra-
decanoylphorbol-13-acetate (TPA; Cell Signaling Technology,
Danvers, MA) for 24 h to differentiate the cells into a macrophage-
like phenotype that adhere to the tissue culture plate. After in-
fection with M.abs (MOI 5), the cells were placed in RPMI medium
with 10% FBS and 30 mg/ml gentamicin to inhibit extracellular re-
plication of M.abs. To conﬁrm that SnPP was not cytotoxic at the
concentrations that were used, THP-1 cell viability was tested by
ﬂow cytometer in the presence of 7-aminoactinomycin D (7-AAD).
No toxicity of SnPP was detected in infected or control cells at 24 h.
Cytotoxicity assay
Cytotoxicity was measured by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) assay using CellTiter 96
Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI).
Electron paramagnetic resonance spectroscopy
EPR spectroscopy was used to measure superoxide levels in M.
abs-infected THP-1 cells. THP-1 cells were activated to macro-
phages and infected with M.abs for 1 h. Cells were then washed
and incubated with antibiotic-free media for different time points.
Treated uninfected cells were used as controls. Cells wereincubated (30 min at 37 °C) with CMH (200 mM), a cell permeable,
superoxide-sensitive spin probe in EPR buffer (pH 7.4). EPR buffer
is a Krebs–HEPES buffer consisting of (in mM): 99 NaCl, 4.69 KCl,
2.5 CaCl2, 1.2 MgSO4, 25 NaHCO3, 1.03 KH2PO4, 5.6 D-glucose, 20
HEPES and supplemented with the metal chelators DETC (5 mM)
and DF (25 mM). After CMH incubation, macrophages were col-
lected in a cell suspension, and 50 ml of the cell suspension was
placed into the Bruker Escan EPR spectrometer. The following EPR
settings were used for all experiments: ﬁeld sweep width, 60.0 G;
microwave frequency, 9.75 GHz; microwave power, 21.90 mW;
modulation amplitude, 2.37 G; conversion time, 10.24 ms; time
constant, 40.96 ms. Levels of superoxide were normalized to the
number of macrophages in each sample.
In situ ROS studies
In situ staining of superoxide (O2) and H2O2 levels were
determined using the superoxide indicator dihydroethidium di-
hydroethidium (DHE) and the ROS indicator 5-(6)-chloromethyl-
20,70-dichlorodihydroﬂuorescein diacetate (CM-H2DCFDA). M.abs
bacteria were labeled with Syto-62 according to manufacturer's
instruction (Invitrogen, Grand Island, NY). TPA-stimulated THP-1
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Fig. 2. p38 is involved in M.abs-mediated HO-1 induction signal transduction
pathway. (A) TPA-differentiated THP-1 cells were infected with M.abs for 1 h, wa-
shed and incubated in media as shown in materials and methods. Cells were col-
lected at different time points. Phosphorylated and total forms of p38MAPK were
determined by immunoblotting. (B) Addition of the p38 inhibitors; SB203580 and
SB202190 reduced HO-1 induction by M.abs.
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Syto-62-labeled M.abs for 1 h, and incubated with media for 4 h at
CO2 incubator. Thirty minutes before the infection was complete,
DHE, and DCF were added to the assigned chambers. After infec-
tion was complete, the medium was removed, and chambers were
washed, and mounted with Vectasheild mounting medium with
DAPI (Vector Laboratories, Burlingame, CA). Images were viewed
using Zeiss 510 Meta Confocal Laser Scanning Microscope.
Western immunoblotting
Total protein lysates were prepared in RIPA buffer containing
protease inhibitors (Thermo Scientiﬁc, Rockford, IL). Lysates were
mixed with equal volume of 2 Laemmli loading dye (Bio-Rad,
Hercules, CA), boiled for 5 min at 95 °C, and loaded onto SDS-PAGE
gels. After running, proteins were transferred to PVDF membranes,
blocked with 5% milk in TBST, and probed with primary antibodies
(p38 MAPK, Phospho-p38 MAPK, Cell Signaling Technology, Dan-
vers, MA, and Anti-MnSOD, Anti-Catalase, Millipore, Billerica, MA)
overnight at 4 °C with constant rocking. Membranes were then
washed three times with TBST, incubated with secondary anti-
bodies for 1 h at room temperature, washed three times with TBST,
and protein were visualized using Pierce chemiluminescence re-
agents (Rockford, IL). Densitometry analyses were performed by
NIH ImageJ.Colony forming unit assay
Colony-forming units (CFUs) for M.abs present within THP-1
cells were determined as described previously [23]. In brief, cell
culture supernatants were removed, and the plates were washed
three times in sterile media. Chilled, chelexed, distilled water was
added (0.3 ml/well) and plates were incubated on ice for 10 mins.
After that, 1.2 ml lysis buffer (0.05% SDS, 5.0% BSA in Fe-free 7H9)
was added to each well, and contents were scraped from plates,
transferred to sterile tubes and centrifuged at 14,000g for 15 min
at 4 °C. Bacteria were resuspended in 200 ml sterile Fe-free 7H9,
and diluted for plating on tryptic soy agar plates (Remel, Lenexa,
KS) for 3–5 days at 37 °C. The number of cfu on the plates was
counted and the mean CFU was calculated.
Phagosome–lysosomes fusion studies
Macrophage-differentiated THP-1 cell were grown on a glass
chamber slide and were infected with Syto-62 labeled M.abs for
1 h in antibiotics-free RPMI medium for 4 h. Two hours before the
infection was complete, LysoTracker Red DND-99 (50 nM) was
added to the cells to label the lysosomes (Invitrogen, Grand Island,
NY). After infection was complete, the medium was removed and
cells were washed and mounted with Vectashield mounting
medium with DAPI (Vector Laboratories, Burlingame, CA). Co-lo-
calization and enumeration studies were performed on Zeiss 510
Meta Confocal Laser Scanning Microscope equipped with 4 lasers:
a Blue Diode 405 nm; an Argon Laser 458/477/488,514 nm; a DPSS
561 nm and a HeNe 633 nm. Both, cells containing bacteria only
and cells containing bacteria that co-localize with a lysosome were
counted in controls and HO-1 inhibited cells. At least 50 cells were
counted per condition in each experiment, and at least three in-
dependent experiments were performed. The results were ex-
pressed as % co-localization (number of cells that contain co-lo-
calized bacteria with lysosomes as percent of total cells counted).
SOD, catalase activity and GSH assays
Activity of antioxidant enzymes in macrophages was measured
using the OxiSelect Catalase Activity Assay Kit (Cell Biolabs Inc, San
Diego, CA) for catalase, GSSG/GSH Quantiﬁcation kit (DOJINDO Inc.
Rockville, MD) for total, oxidized and reduced GSH, and SOD Assay
Kit-WST (DOJINDO Inc. Rockville, MD) to measure intracellular
SOD activity according to the manufacturers' guidelines.
Analysis of data
Means and standard deviations were calculated from in-
dependent experiments. Statistical analysis was done using
GraphPad Prism version 5 for Windows (GraphPad Software, San
Diego, CA). Differences between three or more means were de-
termined using one-way analysis of variance (ANOVA) with Bon-
ferroni post-hoc tests. Error bars represent mean7SEM. All sta-
tistical analyses were considered signiﬁcant at po0.05. Each ex-
periment was analyzed relative to its own control group(s).Results
M.abs infection induces HO-1 expression in macrophages
The role of HO-1 in a variety of infections has been described
before [12,25–28]. Therefore, we sought to study the level of HO-1
expression in M.abs infected and non-infected macrophages. To do
so, we used the human monocytic cell line THP-1. Cells were dif-
ferentiated into macrophages using TPA and then infected with M.
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Fig. 3. HO-1 inhibition suppresses M.abs growth in macrophages. (A) TPA-differentiated THP-1 cells were cultured in the presence of the HO-1 inhibitor SnPP for 24 h,
infected with M.abs for 1 h, and collected 24 h post-infection for CFU determination, as described in materials and methods. SnPP signiﬁcantly inhibited M.abs growth as
detected by CFU (po0.05, n¼5). Results obtained were normalized to vehicle-treated controls. B) TPA-differentiated THP-1 cells were cultured in the presence of different
concentrations of SnPP for 48 h and assayed for toxicity by MTT assay. No toxicity was seen using SnPP concentrations up to 40 mM for 48 h. Results were normalized to
vehicle-treated controls. (C) No growth inhibition of M.abs was detected when bacteria were cultured in RPMI or 7H9 in the presence of different concentrations of SnPP.
(D) TPA-differentiated THP-1 cells were cultured in the presence of different concentrations of CoPP for 24 h, and then infected with M.abs for 1 h. Cells were washed, and
cultured in the presence of CoPP for 24 h. M.abs cfu were counted as described in materials and methods. There was no signiﬁcant difference in M.abs growth in control
versus CoPP treated THP-1 cells (n¼3, p40.05). CFU counts were normalized to vehicle-treated controls. (E) TPA-differentiated THP-1 cells were cultured in the presence of
siRNA for 24 h and then infected with M.abs 1 hr. Cells were washed and cultured for 24 h before collected for CFU assay as described in materials and methods. Signiﬁcant
inhibition of M.abs growth was observed with treatment of THP-1 cells by HO-1 siRNA (po0.05, n¼3) or Nrf2 siRNA (po0.05, n¼2). CFU counts were normalized to Sc-
siRNA-treated controls infected with M.abs. The inset shows decreased HO-1 protein level in the presence of HO-1 siRNA or Nrf2 siRNA. Cells were collected after 24 h of
culture in the presence of HO-1 siRNA, Nrf2 siRNA, or CoPP (HO-1 inducer). Control cells treated with HO-1 siRNA shows no detectable protein by immunoblot (not shown).
CoPP slightly induced HO-1 in the presence of siRNAs as determined by immunoblot (po0.05, n¼3).
M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339 331abs. M.abs grew readily inside macrophages as shown by monitoring
CFU at day 0 till day 1 (Fig. 1A). As shown in Fig. 1B, M.abs infection
signiﬁcantly increased HO-1 expression in a time-dependent man-
ner, beginning 4 h post-infection (po0.001) (Fig. 1B, C).M.abs induces HO-1 expression via p38 MAPK pathway
It has been shown that HO-1 induction is dependent on PI3K/
p38MAPK signaling pathway in many cells, including THP-1 cells
AB
Fig. 4. HO-1 enzymatic products restore M.abs growth reduced by HO-1 inhibition.
TPA-differentiated THP-1 cells were cultured in the presence of SnPP (30 mM) or
HO-1 siRNA for 24 h. Cells were then infected with M.abs and cultured in media
with the addition of either bilirubin (10 mM), biliverdin (10 mM), or CO (10 mM) for
24 h. Cells were collected and M.abs CFU assayed. CFU counts were normalized to
vehicle-treated controls. (A) Both bilirubin and biliverdin signiﬁcantly increased
CFU in SnPP-treated cells (n¼7, po0.05). (B) Biliverdin signiﬁcantly increased CFU
HO-1 siRNA-treated cells (n¼5, po0.05).
M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339332[29,30]. When cells were collected at different times after M.abs
infection, increased phosphorylated p38MAPK was shown starting
at 4 h as shown in Fig. 2A. This is consistent with involvement of
the p38MAPK signaling pathway in M.abs HO-1 induction of HO-1.
Supporting this possibility, the administration of either of the p38
MAPK inhibitors SB203580 (10 mM), or SB202190 (10 mM) reduced
M.abs-induced HO-1 protein expression (Fig. 2B).
HO-1 inhibition suppresses M.abs growth in macrophages
The induction of HO-1 could be very important for bacterial
survival inside the macrophages. HO-1 induces Fe2þ storage as
ferritin, thus limiting the generation of free radicals from free Fe2þ
by Fenton reaction [8,31]. Moreover, both biliverdin and bilirubin
play an antioxidant role that may contribute to the overall cyto-
protective effect of HO-1 [9]. Iron is important for mycobacterial
growth and virulence inside infected macrophages. Our laboratoryand others have shown that controlling iron availability could in-
hibit the growth of Mycobacterium tuberculosis and other bacteria
growing within human macrophages [23,32–34].
Therefore, we examined the effect of altering HO-1 expression
and/or HO-1 activity on M.abs growth inside infected macro-
phages. As shown in Fig. 3, inhibiting HO-1 activity with SnPP
signiﬁcantly (po0.05) decreased the number of M.abs CFU at 24 h,
indicating suppression of bacterial growth in macrophages
(Fig. 3A). The CFU determination was made at 24 h rather than
48 h because the infected THP-1 cells began to show evidence of
detachment after 24 h, which could confound data interpretation.
It is important to mention that in these initial experiments, the
SnPP was added to THP-1 cell cultures 24 h before infection, and
added again after the infection until the time of cell collection.
However, when SnPP was added at the time of infection, no in-
hibition of M.abs growth was observed (not shown). Furthermore,
SnPP had no effect on M.abs phagocytosis as evidenced by a si-
milar level of CFU on day 0 post-infection (data not shown). This
suggests that the impact of HO-1 activity on M.abs growth is due
to a process that occurs early after infection of the host cell.
To rule out any inhibitory effects of SnPP on M.abs or THP-1
cells, cells and bacteria were cultured in the presence of different
concentrations of SnPP and monitored for toxicity. As shown in
Fig. 3, no toxic effects were observed on either the THP-1 cells
(B) or on the bacteria (C) when cultured with SnPP, as determined
by the MTT test or OD600 absorbance, respectively. To further
conﬁrm our results and ensure that no toxic concentrations of
SnPP were used, cells viability was assessed by ﬂow cytometer in
the presence of 7-AAD. No signiﬁcant toxicity of SnPP, was seen in
either control or M.abs-infected THP-1 cells at 24 h (not shown).
Moreover, when similar experiments were performed in the pre-
sence of different concentrations of the HO-1 inducer CoPP, no
signiﬁcant increase in M.abs CFU were detected above untreated
control, as shown in Fig. 3D (p40.05).
To further conﬁrm our results, we inhibited HO-1 by HO-1
siRNA. Inhibiting HO-1 expression by HO-1 siRNA suppressed M.
abs growth inside macrophage-differentiated THP-1 cells as de-
monstrated in Fig. 3E (po0.05). Moreover, inhibiting NrF2, an
upstream signaling factor for HO-1, resulted in a similar effect
(Fig. 3E). Collectively, these results show HO-1 suppression at the
time of infection inhibits M.abs growth in macrophages.
Impact of the HO-1 products bilirubin, biliverdin, and carbon mon-
oxide on M.abs growth
The mechanism whereby M.abs HO-1 upregulation beneﬁts M.
abs intracellular survival was unclear. It has been shown that HO-1
products such as bilirubin, CO, and biliverdin reduce HCV re-
plication in vitro [35,36]. Therefore, we sought to investigate the
effect of HO-1 products on M.abs growth inside infected macro-
phages. In these set of experiments before infecting them with M.
abs we inhibited THP-1 cell HO-1 by SnPP or HO-1 siRNA for 24 h
to prevent any increase in HO-1 activity following M.abs infection.
The cells were then infected with M.abs, and either bilirubin, bi-
liverdin, or CO was added to the infected cells for another 24 h.
Both bilirubin and biliverdin, but not CO, increased the number of
CFU recovered from infected macrophages 24 h post-infection
(Fig. 4). Bilirubin and biliverdin completely restored the CFU count
to control levels with SnPP (Fig. 4A) and partially with HO-1 siRNA
(Fig. 4B) treatment. The ability of bilirubin and biliverdin to restore
CFU counts could be due to their antioxidant activity.
HO-1 inhibition increases phagosome–lysosome fusion
The phagocytosis of mycobacteria by macrophages is followed
by phagosome–lysosome fusion [37,38]. The ability of
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Fig. 5. HO-1 inhibition increases M.abs–lysosomal fusion in macrophages. TPA-differentiated THP-1 cells were cultured in the presence of SnPP or HO-1 siRNA for 24 h.
Macrophages were infected with Syto-62 labeled M.abs for 1 h, and incubated for 4 h. Lysotracker was added 2 h before preparation for confocal microscopy. (A-1) control
cells infected with M.abs (shown in green), lysotracker is shown in red, and nucleus in blue. (A-2) M.abs infection in the presence of HO-1 siRNA. M.abs–lysosomal co-
localization is shown in yellow shows (n¼5). (B) Percent co-localization in SnPP and HO-1 siRNA treated macrophages as compared to control. HO-1 inhibition resulted in a
signiﬁcant increase in the percentage of M.abs showing co-localization with lysosomes (n¼6, po0.05).
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some is an important survival mechanisms used by pathogenic
mycobacteria [39,40]. Therefore, we investigated whether HO-1
induction was involved in the ability of M.abs to inhibit phago-
some–lysosome fusion. TPA-differentiated THP-1 cells were cul-
tured in the presence of SnPP and HO-1 siRNA for 24 h. Macro-
phages were then infected for 4 h with Syto-62-labeled M.abs.
Two hours before the completion of infection, LysoTracker was
added to the cells to label the cells lysosomes. The cells were then
viewed under a confocal microscope and the amount of co-loca-
lization of bacteria with lysosomes was calculated (Fig. 5). At 4 h
after infection there was more co-localization observed in the
macrophages with HO-1 inhibition as compared to controls
(Fig. 5). This result is consistent with the possibility that HO-1
activity contributes to intracellular M.abs survival by playing a role
in limiting phagosome–lysosome fusion.
M.abs infection induces oxidative stress and increases ROS production
HO-1 is also known to serve an anti-inﬂammatory role by de-
creasing intracellular oxidative stress. To assess the oxidative sta-
tus of THP-1 cells infected with M.abs, TPA-differentiated THP-1cells were infected with labeled M.abs for different time points. As
shown in Fig. 6, when compared to non-infected control macro-
phages, M.abs infection increased intracellular superoxide (O2)
and H2O2 production as determined by DHE and DCFH2, respec-
tively (Fig. 6). To conﬁrm the increased ROS production, M.abs
infected macrophages were tested by electron paramagnetic re-
sonance (EPR) using the O2 sensitive spin probe; CMH. As
shown in Fig. 8B, a signiﬁcant increase in CMH radical was de-
tected after 4 h of M.abs infection, indicating more O2 produc-
tion (po0.05) (Fig. 8B).
Since, M.abs increased ROS production, we sought to assess the
levels of antioxidant enzymes and compounds in M.abs infected
macrophages. We ﬁrst measured the levels of MnSOD and catalase
protein levels in M.abs infected macrophages and controls at dif-
ferent time points. As shown in Fig. 7A, there were no differences
between the levels of MnSOD and catalase protein over time (A).
Similarly, there were no signiﬁcant differences in either SOD
(Fig. 7B) or catalase activity (C) at the different time points post-
infection with M.abs (p40.05).
However, the picture was not the same when we measured the
levels of reduced and oxidized GSH in M.abs infected and non-
infected THP-1 cells. As observed in Fig. 7D, a decrease in the ratio
Fig. 6. M.abs infection increases THP-1 cell ROS production. TPA-differentiated THP-1 cells were infected with Syto-62 labeled M.abs for 4 h, and loaded with 10 mM DCFH2
or DHE for the 30 min, washed and prepared for confocal microscopy study. Panels A and C are control cells with no infection showing minimal DCF or DHE ﬂuorescence.
Panel B shows increased DCF ﬂuorescence and Panel D shows increased DHE ﬂuorescence after 4 h of infection. Syto-62 labeled M.abs bacteria are shown inside the cells in
red or green (n¼4).
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after 4 and 6 h of infection compared to non-infecting controls,
consistent with increased GSH turnover in M.abs infected cells as a
result of increased oxidative stress (D).
HO-1 inhibition using SnPP increased ROS production as de-
monstrated by increased DHE and DCF ﬂuorescence (Fig. 8A), and
EPR measurements (B). Combining SnPP inhibition with M.abs
infection led to more ROS production (Fig. 8B). This suggests that
induction of HO-1 following M.abs infection of macrophages may
serve to limit to levels of intracellular ROS.Discussion
Mycobacterium abscessus is a rapidly growing mycobacterial
species that can cause severe lung disease. Lung infections caused
by M.abs are an emerging problem in the U.S. and many parts of
the world, particularly in CF patients. Many M.abs strains are
multi-drug resistant, and responsible for difﬁculties in patients
undergoing lung transplantation [41]. M.abs infects and multiplies
within human macrophages, indicating an ability of the bacteria to
evade macrophage antimicrobial systems. In the current work, we
sought to examine the early stages of M.abs infection inside
macrophages, with a particular emphasis on the role of HO-1 in
this process. We also deﬁned the role of ROS and anti-oxidants
inside macrophages infected with M.abs.
Our results show that M.abs infection increased O2 and H2O2production as indicated by increased ﬂuorescence of DHE and DCF,
respectively. Our EPR results conﬁrmed the increase O2 during
the ﬁrst hours of infection. Although protein levels and activities of
SOD and catalase in the macrophages were not increased upon M.
abs infection, reduced GSH was signiﬁcantly decreased, indicating
increased GSH turnover and oxidative stress. In contrast to SOD
and catalase, HO-1 was induced during mycobacterial infection.
This was not surprising as it was previously reported that HO-1 is
induced in both infected macrophages and mice during M. tu-
berculosis infection [20,21]. HO-1 is highly inducible in response to
a variety of stressful stimuli such as physical stress, reactive oxy-
gen species (ROS), UV irradiation, endotoxins, and hypoxia and
provide protection to cells and tissues against oxidative and in-
ﬂammatory injury [10]. Induction of HO-1 is cytoprotective to host
cells. Both biliverdin and bilirubin have antioxidant properties and
can protect cells from a variety of ROS insults [9]. In addition, HO-1
prevents free Fe2þ accumulation within cell through sequestrating
it by ferritin and thus, limiting the generation of free radicals via
the Fenton reaction [8,31]. CO produced by HO-1 has been re-
ported to suppress apoptosis and modulate levels of pro-in-
ﬂammatory cytokines, NO, and prostaglandins [42–44].
Since HO-1 is directly linked to macrophage Fe metabolism,
HO-1 induction could contribute to pathogenesis by providing a
new source of Fe for bacterial growth and replication. Alter-
natively, biliverdin/bilirubin production could improve the en-
vironment for M.abs growth. Finally, inhibition of macrophage
apoptosis resulting from HO-1 induction could enhance M.abs
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Fig. 7. M.abs infection increases THP-1 cell GSH turnover, but not MnSOD or catalase protein expression or activity. TPA-differentiated THP-1 cells were infected with M.abs
for 1 h, washed and cultured in media until collected at different time points. Immunoblotting and enzyme activity were determined as described in materials and methods.
(A) No difference in catalase or MnSOD protein (Panel A), SOD activity (Panel B, n¼3, p40.05) or catalase activity (Panel C, n¼3, p40.05) was observed between M.abs-
infected and non-infected THP-1 cells at different points. (Panel D) Cells were then collected and studied for reduced glutathione (GSH), and oxidized glutathione (GSSG)
levels as described in materials and methods. M.abs signiﬁcantly decreased the ratio of GSH/GSSG, which reﬂects glutathione turnover (n¼3, po0.05). Data counts in B–D
were normalized to uninfected controls.
M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339 335survival in macrophages. In fact, it was found that HO-1 favors
pathogen dormancy in M. tuberculosis infections [21], and pro-
motes the establishment of the malaria liver stage of infection
[45]. Therefore, we assessed the importance of inhibiting HO-1 on
mycobacterial growth inside infected macrophages.
We demonstrated that M.abs infection robustly induces HO-1
expression in the human macrophage-like THP-1 cells. Production
of HO-1 was p38 MAPK-dependent, and p38 inhibitors suppressed
HO-1 induction. We also demonstrated that pretreatment with
HO-1 chemical inhibitors SnPP signiﬁcantly inhibited M.abs
growth inside macrophages, indicating the need of HO-1 for M.abs
inside infected macrophages. It is worth mentioning that SnPP wasadded 24 h before infection to inhibit HO-1, and adding SnPP at
the time of infection did not show the same inhibitory effect.
Furthermore, we showed that inhibiting HO-1 using HO-1 siRNA
or the HO-1 upstream signaling molecule; Nrf2 using Nrf2 siRNA
resulted in similar inhibitory effects. In contrast, inducing HO-1
using CoPP did not increase M.abs intracellular growth.
In seeming contrast to our ﬁndings, it has been shown that HO-
1-deﬁcient (Hmox1/) mice were more susceptible to myco-
bacterial infection, and failed to mount a protective granulomatous
response [46,47]. However, it is possible that the HO-1 effect in
these studies extends beyond the macrophages and/or the lung
alone since in murine models mycobacterial infection leads to
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Fig. 8. HO-1 inhibition increase ROS production. TPA-differentiated THP-1 cells were infected with M.abs for 1 h, washed and cultured with media for 4 h. Cells were then
loaded with DCFH2 or DHE for the 30 min, washed and prepared for confocal microscopy study. (A) HO-1 inhibition using SnPP increased ROS production as shown by DHE
(A and B) and DCF ﬂuorescence (C and D). (B) TPA-differentiated THP-1 cells were infected with M.abs for 4 h. Cells were then collected and studied for O2 production by
EPR as described in materials and methods. CMH is the spin probe 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine hydrochloride, KDD is the EPR buffer. A
signiﬁcant increase in O2 production was observed at 4 h post-M.abs infection (po0.05), and when infection is combined with HO-1 inhibition (po0.0001). Inhibiting
HO-1 also increased ROS production (po0.0001) (n¼5).
M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339336systemic disease. Complete inhibition of HO-1 in whole body tis-
sues might affect other functional roles of HO-1 in mycobacterial
resistance.Our data show that the presence of bilirubin and/or biliverdin
reversed the negative impact of HO-1 inhibition on M.abs growth
in THP-1 cells. This suggests that these HO-1 products may be
M.Y. Abdalla et al. / Redox Biology 4 (2015) 328–339 337critical to the growth enhancing effect of HO-1 for M.abs in mac-
rophages. The role of bilirubin and biliverdin as antioxidants ex-
tend beyond simply scavenging free radicals [48] to interfering
with ROS production. It has been shown that decreased heme
content due to HO-1 activation limits heme availability for the
assembly of the functional NADPH oxidase subunits [49,50], and
administration of the HO-1 inhibitor SnPP reversed this effect and
increased NADPH [50]. The mechanism of inhibition could be
partly mediated by bilirubin [50]. This is consistent with our re-
sults, where inhibiting HO-1 with SnPP increased ROS production
as indicated by EPR and increased DHE and DCF ﬂuorescence. The
ability of bilirubin and biliverdin, but not CO, to reverse the effect
of SnPP and increase M.abs growth inside macrophages supports a
role for HO-1 activity and/or induction for M.abs survival inside
macrophages. Further studies are still needed to deﬁne the exact
mechanisms involved in enhancing M.abs intracellular growth.
The role of ROS in macrophage killing of intracellular myco-
bacteria is still debated. The enhanced bactericidal effect of in-
creased ROS production in infected macrophages has been pre-
viously shown [51–53]. It has been suggested that M. tuberculosis
may be more sensitive to ROS generation than other bacteria
[52,53], and that minimizing the macrophage oxidative burst is
one mechanism of mycobacterial intracellular survival [51]. On the
other hand, it was reported that an oxidative environment could
promote M.abs growth, and adding antioxidants and reducing
intracellular oxidative stress could decrease intracellular growth of
mycobacteria [54,55]. Combining our results with others, it could
be concluded that both ROS and antioxidants are important for
controlled, balanced intracellular environment that promotes
mycobacterial killing and provides optimal conditions for func-
tional macrophages against mycobacteria and other pathogens.
The effect of the HO-1 products could involve interaction with
bacterial enzymatic activity and cellular functions. Iron inhibits the
nonstructural 5B (NS5B) RNA-dependent RNA polymerase of HCV
[56]. Moreover, biliverdin, and bilirubin were shown to inhibit
HCV NS3/4A protease in liver cells and in cell-free assays [57,58].
A component of the intracellular survival mechanism of my-
cobacteria in human macrophages is the inhibition of macrophage
phagosome–lysosome fusion [59,60]. Our results show that in-
hibiting HO-1 increased mycobacteria–lysosome co-localization
and thus phagosome–lysosome fusion in M.abs infected macro-
phages. Increased phagosome–lysosome fusion in macrophages is
important mechanism for mycobacterial killing. Mycobacteria
have evolved multiple ways to evade or escape phagosome–lyso-
some fusion in macrophages. Tools for inhibiting phagosome–ly-
sosome fusion ranged between producing ammonia in abundance
[59], alkalizing the intralysosomal compartment [61], altered cal-
modulin-dependent signal transduction, and abundant iron
availability [62]. In the latter, it was shown using dominant ne-
gative Rab5, that fusion of phagosomes with early endosomes and
an adequate iron supply are important for mycobacteria to inhibit
the phagosome maturation process [62]. This is consistent with
our results that inhibiting HO-1 enhanced M.abs lysosomal co-
localization, i.e. phagosome–lysosome fusion. This could be par-
tially attributed to the reduced Fe availability that might result
from lower HO-1 activity.
In summary, our results suggest that inhibiting HO-1 limits M.
abs growth inside macrophages at the early stages of infection,
and that reducing HO-1 products may enhance the ability of the
macrophage to control M.abs infection. Further investigations are
still required to deﬁne the detailed mechanisms involved and the
potential for this to be translated to new forms of therapy against
this emerging infection.Acknowledgments
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